A total of 297 employees to be laid off.
The nanomedicines market is worth billions. Tarun Pandotra reviews developments in the sector.
Scrutiniseing the market access situation for people with rare bleeding disorders.
The steps required for successful market access.
11/06/2017August 29, 2017
19/09/2017August 21, 2017
‘Pricing and Market Access Outlook: 2017 Edition’ includes fresh analysis from QuintilesIMS of market forces and pricing policy based on facts and figures behind approvals of new molecular entities in 2015.